Lemaitre Vascular (LMAT) Misses Q3 EPS by 2c

October 28, 2021 4:24 PM EDT

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.30, $0.02 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $38.4 million versus the consensus estimate of $39.05 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings